NCT06981832

Brief Summary

Physical activity is defined as 'any bodily movement produced by skeletal muscles that results in an energy expenditure greater than that of the resting metabolism'. Physical activity includes 'activities of daily living, physical exercise and sporting activities'. The scientific community is agreed in recognising the benefits of physical activity, both in healthy individuals and in those suffering from chronic diseases. With this in mind, the law of 2 March 2022 allows doctors to prescribe Adapted Physical Activity. In the case of chronic renal failure, there are a number of factors that can limit physical activity in haemodialysis patients, such as anaemia, nutritional status and post-dialysis fatigue. However, the risks associated with a sedentary lifestyle play a role in the development of chronic disease, in particular hypertension and diabetes. The benefits of physical activity have been widely identified in chronic renal failure, particularly in terms of cardiovascular and muscular function. More generally, physical activity has a positive impact on physical, psychological and social quality of life (increase in overall quality of life score, improved sleep, reduced pain, etc.). Physical activity should therefore be encouraged in patients with chronic renal failure, whether on dialysis or not, whatever their age. The aim of this study is to assess whether individualised support (from an advanced practice nurse and an adapted physical activity teacher) improves the practice of physical activity at home in patients who have been on haemodialysis for less than a year, and whether this improvement is sustainable over time.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
24mo left

Started Oct 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Oct 2025Apr 2028

First Submitted

Initial submission to the registry

May 13, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 21, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

October 28, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2028

Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

1.9 years

First QC Date

May 13, 2025

Last Update Submit

December 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patients with a level of physical activity considered moderate or high, assessed using the physical activity questionnaire (IPAQ) 6 months after the start of the intervention

    The level of physical activity according to the IPAQ questionnaire is defined as follows: 1. \- Low * No activity is reported OR * Some activity is reported but without reaching levels 2 or 3. 2. \- Moderate Corresponds to one of the following 3 criteria: * 3 or more days of intense activity lasting at least 20 minutes a day OR * 5 days or more of moderate intensity activity and/or walking for at least 30 minutes a day OR * 5 days or more of activity combining walking, moderate or high intensity activities, thus achieving at least 600 MET-minutes/week. 3. \- High Corresponds to one of the 2 following criteria: * Intense activity on at least 3 days a week, achieving at least 1500 MET-minutes/week OR * 7 or more days of activity combining walking and moderate or high-intensity activities, achieving at least 3000 MET-minutes/week.

    6 months after the start of the intervention

Study Arms (2)

Personalised support (advanced practice nurse and adapted physical activity teacher)

EXPERIMENTAL
Behavioral: Personalised support (advanced practice nurse and adapted physical activity teacher)

Standard support (advanced practice nurse)

ACTIVE COMPARATOR
Behavioral: Standard support (advanced practice nurse)

Interventions

Personalised support (advanced practice nurse and adapted physical activity teacher)

Personalised support (advanced practice nurse and adapted physical activity teacher)

Standard support (advanced practice nurse)

Standard support (advanced practice nurse)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient over 18 years of age
  • Patient who has been receiving haemodialysis for less than a year
  • Patient with medical prescription for physical activity
  • Patient able to understand the protocol and having given consent to participate in the research,
  • Patient affiliated to the social security system or entitled beneficiary
  • Patient with physical activity considered low or moderate according to the IPAQ questionnaire

You may not qualify if:

  • Patients with medical contraindications to adapted physical activity
  • Patients with a lower limb amputation
  • Patients undergoing peritoneal dialysis
  • Patient with a peritoneal dialysis project
  • Patient participating in another clinical research protocol with an impact on the research objectives
  • Patient already randomised in the study
  • Patients under guardianship, curatorship or deprived of liberty
  • Patient under activated future protection mandate
  • Patient under family habilitation
  • Patient under court protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Departemental Vendée

La Roche-sur-Yon, 85925, France

RECRUITING

Study Officials

  • Emilie VINCENT

    Centre H

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2025

First Posted

May 21, 2025

Study Start

October 28, 2025

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

April 1, 2028

Last Updated

December 23, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations